NCT00633139View on ClinicalTrials.gov

Long-term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

13

Participants

Timeline

Start Date

January 22, 2007

Primary Completion Date

November 25, 2008

Study Completion Date

November 25, 2008

Conditions

Late Infantile Metachromatic Leukodystrophy

Interventions

BIOLOGICAL

Recombinant human Arylsulfatase A (rhASA)

intravenous infusion, every other week for 26 weeks

Trial Locations (1)

2650

PhaseOneTrials A/S, Hvidovre

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Shire

INDUSTRY